Journal Article (Review Article) DKFZ-2020-00736

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma.

 ;  ;  ;  ;  ;  ;

2020
Molecular Diversity Preservation International Basel

International journal of molecular sciences 21(7), 2367 () [10.3390/ijms21072367]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Although melanoma is one of the most immunogenic tumors, it has an ability to evade anti-tumor immune responses by exploiting tolerance mechanisms, including negative immune checkpoint molecules. The most extensively studied checkpoints represent cytotoxic T lymphocyte-associated protein-4 (CTLA-4) and programmed cell death protein 1 (PD-1). Immune checkpoint inhibitors (ICI), which were broadly applied for melanoma treatment in the past decade, can unleash anti-tumor immune responses and result in melanoma regression. Patients responding to the ICI treatment showed long-lasting remission or disease control status. However, a large group of patients failed to respond to this therapy, indicating the development of resistance mechanisms. Among them are intrinsic tumor properties, the dysfunction of effector cells, and the generation of immunosuppressive tumor microenvironment (TME). This review discusses achievements of ICI treatment in melanoma, reasons for its failure, and promising approaches for overcoming the resistance. These methods include combinations of different ICI with each other, strategies for neutralizing the immunosuppressive TME and combining ICI with other anti-cancer therapies such as radiation, oncolytic viral, or targeted therapy. New therapeutic approaches targeting other immune checkpoint molecules are also discussed.

Classification:

Note: #EA:A370#LA:A370# / #DKFZ-MOST-Ca181#

Contributing Institute(s):
  1. KKE Dermatoonkologie (A370)
Research Program(s):
  1. 311 - Signalling pathways, cell and tumor biology (POF3-311) (POF3-311)

Appears in the scientific report 2020
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2020-04-03, last modified 2025-11-13



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)